Ariel Bellamy knows what it means to be a hospital administrator, having previously worked as an assistant administrator since July at Siskin Subacute West. Now, she will take on new responsibilities ...
The 2021 approval by regulatory agencies of belimumab, a B lymphocyte stimulator (BLyS) inhibitor, and the 2022 approval of anifrolumab, a type I interferon inhibitor, has increased the therapeutic ...
verfasst von: Katharina Kerschan-Schindl, Harald Widhalm, Anna Pataraia, Peter Nicolakis, Martin Frossard, Mohammad Keilani, Michael Mickel, Stefan Hajdu, Richard Crevenna In addition to this ...